CRSP – Knox Daily

Analysts Viewpoint

CRISPR Therapeutics AG’s recent filing unveils that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $0.83 million

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Stock Earnings

CRISPR Therapeutics AG’s recent filing unveils that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $0.83 million

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

In a filing, CRISPR Therapeutics AG revealed its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.67 million

Stock Earnings

CRISPR Therapeutics AG’s recent filing unveils that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.67 million

Insiders Updates

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

CRISPR Therapeutics AG’s recently made public that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $1.67 million

Analysts Viewpoint

CRISPR Therapeutics AG’s recent filing unveils that its General Counsel and Secretary KASINGER JAMES R. unloaded Company’s shares for reported

Stock Earnings

In a filing, CRISPR Therapeutics AG revealed its General Counsel and Secretary KASINGER JAMES R. unloaded Company’s shares for reported

Tag: CRSP